KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.
D000818:Animals; D002316:Cardiotonic Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D066298:In Vitro Techniques; D015640:Ion Channel Gating; D017202:Myocardial Ischemia / Q000188:drug therapy*; D026941:Sodium Channel Blockers / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*; D013830:Thiadiazoles / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology*
C111116:3-(3-(N-(2-(3,4-dimethoxyphenyl)ethyl)-N-methylamino)propyloxy)-5-phenyl-1,2,4-thiadiazole; D002316:Cardiotonic Agents; D026941:Sodium Channel Blockers; D013830:Thiadiazoles